FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental ANDA for pravastatin sodium, enabling a generic version of pravastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)